Exane Derivatives’s Alector ALEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,594
Closed -$65.5K 774
2022
Q1
$65.5K Sell
4,594
-389
-8% -$6.15K 0.02% 537
2021
Q4
$103K Buy
4,983
+4,866
+4,159% +$110K 0.02% 439
2021
Q3
$2.67K Hold
117
﹤0.01% 782
2021
Q2
$4.37K Buy
+117
New +$2.21K ﹤0.01% 784
2021
Q1
Sell
-5,900
Closed -$89.3K 896
2020
Q4
$89.3K Hold
5,900
0.03% 409
2020
Q3
$62.2K Buy
+5,900
New +$95.4K 0.02% 359

Other funds holding ALEC

Exane Derivatives's ALEC Position: Q2 2022 in Review

Exane Derivatives sold out of Alector (ALEC) in Q2 2022, closing a stake of 4,594 shares — an estimated $65.5K sold.

Exane Derivatives first reported a position in ALEC in Q3 2020 and held it in 6 quarters. The position peaked at $103K in Q4 2021. 153 funds tracked by Wall St. Rank hold ALEC as of Q2 2022.

  • Exane Derivatives reported no remaining Alector position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 4,594 Alector shares in Q2 2022, an estimated $65.5K.
  • Exane Derivatives first reported a position in Alector in Q3 2020 and held it in 6 quarters.
  • Exane Derivatives's Alector position peaked at $103K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held Alector as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.